ClinicalTrials.gov
public full text
Public Domain
Study in Subjects With Moderate Atopic Dermatitis
This is a Phase 2, randomized, double-blind, vehicle-controlled, parallel-group study to evaluate the safety and efficacy of ALX-101 Gel 5% and a matching ALX-101 Gel Vehicle when applied topically twice daily for 56 days in adult and adolescent subjects with moderate atopic dermatitis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study in Subjects With Moderate Atopic Dermatitis#994309
- Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis#1007571
- Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis#844685
- Observational Evaluation of Atopic Dermatitis in Pediatric Patients#1096390
- Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis#876989
Record · ID 1093061
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive